X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (389) 389
Book Review (29) 29
Publication (15) 15
Conference Proceeding (8) 8
Book Chapter (2) 2
Newspaper Article (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (162) 162
index medicus (133) 133
female (100) 100
male (100) 100
urology & nephrology (95) 95
middle aged (80) 80
adult (76) 76
proteinuria (48) 48
aged (45) 45
nephrology (38) 38
transplantation (38) 38
risk factors (37) 37
disease progression (35) 35
diseases of the genitourinary system. urology (29) 29
treatment outcome (29) 29
glomerulonephritis (28) 28
retrospective studies (26) 26
iga nephropathy (25) 25
kidney transplantation (25) 25
kidney - pathology (23) 23
adolescent (22) 22
glomerular filtration rate (22) 22
prognosis (21) 21
immunosuppressive agents - therapeutic use (20) 20
young adult (20) 20
disease (19) 19
proteinuria - etiology (19) 19
biopsy (18) 18
prospective studies (18) 18
chronic kidney disease (17) 17
creatinine - blood (17) 17
proteinuria - drug therapy (17) 17
time factors (17) 17
angiotensin-converting enzyme inhibitors - therapeutic use (16) 16
follow-up studies (16) 16
nephropathy (16) 16
surgery (16) 16
focal segmental glomerulosclerosis (14) 14
hypertension (14) 14
obesity (14) 14
renin-angiotensin system - drug effects (14) 14
glomerulonephritis, iga - complications (13) 13
immunology (13) 13
kidney - physiopathology (13) 13
mortality (13) 13
nephrotic syndrome (13) 13
obesity - complications (13) 13
renal dialysis (13) 13
animals (12) 12
chronic kidney-disease (12) 12
kidney diseases (12) 12
kidney failure, chronic - etiology (12) 12
progression (12) 12
risk (12) 12
spain (12) 12
therapy (12) 12
abridged index medicus (11) 11
acute kidney injury - etiology (11) 11
child (11) 11
drug therapy, combination (11) 11
glomerulonephritis, iga - pathology (11) 11
hematuria (11) 11
hemodialysis (11) 11
aged, 80 and over (10) 10
care and treatment (10) 10
eculizumab (10) 10
kidney diseases - etiology (10) 10
peripheral vascular disease (10) 10
acute renal failure (9) 9
albuminuria (9) 9
blood-pressure (9) 9
clinical research (9) 9
complement (9) 9
glomerular-filtration-rate (9) 9
kaplan-meier estimate (9) 9
kidney function tests (9) 9
kidneys (9) 9
outcomes (9) 9
renal failure (9) 9
urologic and male genital diseases (9) 9
acute-renal-failure (8) 8
analysis (8) 8
blood pressure (8) 8
complement activation (8) 8
converting enzyme-inhibition (8) 8
diagnosis (8) 8
dialysis (8) 8
failure (8) 8
glomerulonephritis, iga - drug therapy (8) 8
hematuria - etiology (8) 8
immunosuppression (8) 8
immunosuppressive agents - adverse effects (8) 8
kidney (8) 8
kidney failure, chronic - therapy (8) 8
medicine, general & internal (8) 8
nephritis (8) 8
oxidative stress (8) 8
proteinuria - physiopathology (8) 8
research (8) 8
vitamin d (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 11/2015, Volume 88, Issue 5, pp. 1153 - 1160
Journal Article
NEFROLOGIA (English Edition), ISSN 2013-2514, 09/2015, Volume 35, Issue 5, pp. 421 - 447
Haemolytic uraemic syndrome (HUS) is a clinical entity defined as the triad of nonimmune haemolytic anaemia, thrombocytopenia, and acute renal failure, in... 
Atypical haemolytic uraemic syndrome | Thrombotic microangiopathy | Microangiopatía trombótica | Eculizumab | Complement | Complemento | Síndrome hemolítico urémico atípico
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, pp. e0128575 - e0128575
Journal Article
by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Bakris, George and Correa-Rotter, Ricardo and Hou, Fan-Fan and Hou, Fanfan and Kitzman, Dalane W and Kohan, Donald and Makino, Shinya and Makino, Hirofumi and McMurray, John J V and Melnick, Joel Z and Miller, Michael G and Miller, Alan and Miller, Steven and Pergola, Pablo E and Pergola, Pablo and Perkovic, Vlado and Tobe, Sheldon and Yi, Joo Hark and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Maffei, Laura and Juncos, Luis and de Arteaga, Javier and Greloni, Gustavo and Farias, Eduardo and Zucchini, Alfredo and Vogel, Daniel and Cusumano, Ana and Santos, Juan and Fraenkel, Margaret and Gallagher, Martin and Davis, Tim and Acharya, Shamasunder and Cooke, Duncan and Suranyi, Michael and Roger, Simon and Toussaint, Nigel and Pollock, Carol and Chan, Doris and Stranks, Stephen and MacIsaac, Richard and Endre, Zoltan and Schmidt, Alice and Schmidt, Rebecca and Prager, Rudolf and Mayer, Gert and Warling, Xavier and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Costa e Forti, Adriana and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Moura Neto, Jose Andrade and Deboni, Luciane and de Lourdes Noronha, Irene and Cercato, Cintia and Prompt, Carlos Alberto and Zanella, Maria and Rassi, Nelson and D'Avila, Domingos and Milagres, Rosangela and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Amodeo, Celso and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Bajaj, Harpreet Singh and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Tam, Paul and Rabbat, Christian and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Munoz, Rodrigo and ... and SONAR Comm Investigators and SONAR Committees and Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | ENDOTHELIN | ALBUMINURIA | NEPHROPATHY | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Serum Albumin, Human - urine | Young Adult | Aged, 80 and over | Adult | Female | Diabetic Nephropathies - prevention & control | Endothelin A Receptor Antagonists - therapeutic use | Diabetic Nephropathies - urine | Glomerular Filtration Rate | Double-Blind Method | Endothelin A Receptor Antagonists - administration & dosage | Administration, Oral | Treatment Outcome | Creatinine - urine | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - prevention & control | Atrasentan - therapeutic use | Creatinine - blood | Aged | Atrasentan - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Renal Insufficiency, Chronic - urine | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Randomization | Renin | Motivation | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
Kidney International, ISSN 0085-2538, 02/2018, Volume 93, Issue 2, pp. 450 - 459
Pregnancy-associated atypical hemolytic uremic syndrome (aHUS) refers to the thrombotic microangiopathy resulting from uncontrolled complement activation... 
postpartum | cesarean section | eculizumab | complement | hemolytic uremic syndrome | GENE-MUTATIONS | SYSTEM | ACTIVATION | COMPLEMENT INHIBITOR ECULIZUMAB | PREECLAMPSIA | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | THROMBOTIC MICROANGIOPATHY | UROLOGY & NEPHROLOGY | OUTCOMES | AHUS | Complement Activation | Humans | Immunosuppressive Agents - therapeutic use | Complement C3b Inactivator Proteins - genetics | Atypical Hemolytic Uremic Syndrome - immunology | Postpartum Period | Plasma Exchange | Thrombotic Microangiopathies - epidemiology | Thrombotic Microangiopathies - genetics | Adult | Female | Registries | Retrospective Studies | Atypical Hemolytic Uremic Syndrome - genetics | Parity | Thrombotic Microangiopathies - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Atypical Hemolytic Uremic Syndrome - therapy | Risk Factors | Atypical Hemolytic Uremic Syndrome - epidemiology | Treatment Outcome | Gene Conversion | Pregnancy | Cesarean Section | Spain - epidemiology | Pregnancy Complications - genetics | Thrombotic Microangiopathies - therapy | Mutation | Complement Factor H - genetics | Pregnancy Complications - epidemiology | Pregnancy Complications - immunology | Pregnancy Complications - therapy | Renal Dialysis | Thrombotic microangiopathy | Complement activation | Hemolytic uremic syndrome | Hemodialysis | Pregnancy complications | Gene conversion | Patients | Cesarean section | Postpartum | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10084, pp. 2117 - 2127
Summary Background IgA nephropathy is thought to be associated with mucosal immune system dysfunction, which manifests as renal IgA deposition that leads to... 
Internal Medicine | LONG-TERM | ACE-INHIBITORS | MEDICINE, GENERAL & INTERNAL | THERAPY | PHARMACOKINETICS | RISK | HEMATURIA | RENAL SURVIVAL | REGION | Glucocorticoids - administration & dosage | Glomerular Filtration Rate | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Glomerulonephritis, IGA - drug therapy | Drug Delivery Systems | Dose-Response Relationship, Drug | Adult | Female | Budesonide - administration & dosage | Glomerulonephritis, IGA - pathology | Clinical trials | Care and treatment | Chronic kidney failure | Immunoglobulin A | Steroids | Kidney diseases | Analysis | Corticoids | Budesonide | Nephrology | Nephritis | Risk factors | Osteoporosis | Cell activation | IgA nephropathy | Enzyme inhibitors | Peptidyl-dipeptidase A | Biocompatibility | Diagnosis | Drug dosages | Immunoglobulins | Corticosteroids | Filtration | Committees | Metabolism | Appendix | Immunosuppression | Inhibitors | Diet | Collection | Adults | Titration | Added value | Circulation | Kidney transplantation | Cell proliferation | Glomerulonephritis | Drugs | Renal function | Immunoglobulin G | Medical services | Antibodies | Stimulation | Drug delivery | Optimization | Reduction | Intestine | Lymphocytes | Safety engineering | Constrictions | Attenuation | Safety | Drug therapy | Immune system | Antigen-antibody complexes | Urine | Hypertension | Excretion | Kidneys | Complications | Diabetes mellitus | Health risks | Risk reduction | Albumin | Gastrointestinal tract | Pharmacology | Inflammation | Lymphocytes B | Biopsy | Angiotensin | Pharmacokinetics | Index Medicus | Abridged Index Medicus | Clinical Medicine | Urologi och njurmedicin | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 02/2019, Volume 19, Issue 2, pp. 434 - 447
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 10/2016, Volume 50, Issue 9, pp. 779 - 789
Journal Article